Schubert & Co’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
Other funds holding MYOV
Schubert & Co's MYOV Position: Q1 2023 in Review
Schubert & Co sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 3 shares — an estimated $81 sold.
Schubert & Co first reported a position in MYOV in Q4 2022 and held it in 1 quarter. The position peaked at $81 in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.
- Schubert & Co reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
- Schubert & Co sold 3 Myovant Sciences Ltd. shares in Q1 2023, an estimated $81.
- Schubert & Co first reported a position in Myovant Sciences Ltd. in Q4 2022 and held it in 1 quarter.
- Schubert & Co's Myovant Sciences Ltd. position peaked at $81 in Q4 2022.
- 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.
Based on Schubert & Co's 13F filing for Q1 2023, filed 2 May 2023.